Grantham, Mayo, Van Otterloo & Co (GMO)
ARVN icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Arvinas ARVN Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio ARVN Stock Details ARVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-16,500
Closed -$665K – 749
2020
Q1 		$665K Buy
+16,500
New +$772K 0.01% 558

Other funds holding ARVN

CPI
Canaan Partners IX Menlo Park, California $87.5M AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s ARVN Position: Q2 2020 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Arvinas (ARVN) in Q2 2020, closing a stake of 16,500 shares — an estimated $665K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ARVN in Q1 2020 and held it in 1 quarter. The position peaked at $665K in Q1 2020. 142 funds tracked by Wall St. Rank hold ARVN as of Q2 2020.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Arvinas position as of Q2 2020 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 16,500 Arvinas shares in Q2 2020, an estimated $665K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Arvinas in Q1 2020 and held it in 1 quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Arvinas position peaked at $665K in Q1 2020.
  • 142 funds tracked by Wall St. Rank held Arvinas as of Q2 2020.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2020, filed 13 Aug 2020.